Abstract Individuals with type 2 diabetes (T2D) have a higher fracture risk compared to non-diabetics, even though their areal bone mineral density is normal to high. Identifying the mechanisms whereby diabetes lowers fracture resistance requires well-characterized rodent models of diabetic bone disease. Toward that end, we hypothesized that bone toughness, more so than bone strength, decreases with the duration of diabetes in ZDSD rats. Bones were harvested from male CD(SD) control rats and male ZDSD rats at 16 weeks (before the onset of hyperglycemia), at 22 weeks (5-6 weeks of hyperglycemia), and at 29 weeks (12-13 weeks of hyperglycemia). There were at least 12 rats per strain per age group. At 16 weeks, there was no difference in either body weight or glucose levels between the two rat groups. Within 2 weeks of switching all rats to a diet with 48 % of kcal from fat, only the ZDSD rats developed hyperglycemia ([250 mg/dL). They also began to lose body weight at 21 weeks. CD(SD) rats remained normoglycemic (\110 mg/dL) on the high-fat diet and became obese ([600 g). From micro-computed tomography (lCT) analysis of a lumbar vertebra and distal femur, trabecular bone volume did not vary with age among the non-diabetic rats but was lower at 29 weeks than at 16 weeks or at 22 weeks for the diabetic rats. Consistent with that finding, lCT-derived intra-cortical porosity (femur diaphysis) was higher for ZDSD following *12 weeks of hyperglycemia than for age-matched CD(SD) rats. Despite an age-related increase in mineralization in both rat strains (lCT and Raman spectroscopy), material strength of cortical bone (from three-point bending tests) increased with age only in the non-diabetic CD(SD) rats. Moreover, two other material properties, toughness (radius) and fracture toughness (femur), significantly decreased with the duration of T2D in ZDSD rats. This was accompanied by the increase in the levels of the pentosidine (femur). However, pentosidine was not significantly higher in diabetic than in non-diabetic bone at any time point. The ZDSD rat, which has normal leptin signaling and becomes diabetic after skeletal maturity, provides a pre-clinical model of diabetic bone disease, but a decrease in body weight during prolonged diabetes and certain strain-related differences before the onset of hyperglycemia should be taken into consideration when interpreting diabetes-related differences.
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Introduction
There is a growing population of individuals with diabetes who are prone to fractures [1, 2] . A meta-analysis of epidemiological studies estimated that individuals with type 2 diabetes (T2D) are approximately two times more likely to suffer a hip fracture than non-diabetics of the same age and gender [3] . Furthermore, greater fracture risk in diabetic patients is disproportionate to differences in areal bone mineral density (aBMD) between diabetic and age-matched healthy individuals [4, 5] , and the incidence of hip fracture is higher in long-term compared with short-term diabetes [3, 6] . These observations stress the need for (i) understanding how the duration of diabetes affects bone beyond aBMD and (ii) developing treatment strategies that improve the inherent quality of the bone matrix beyond simply increasing the amount of bone. The clinical observation that the age-adjusted fracture risk for a given femoral neck aBMD is higher among adults with T2D than among non-diabetic adults [7] suggests that T2D lowers fracture resistance through deleterious effects on the material properties of bone. Clinical studies using peripheral computed tomography (HR-pQCT), an imaging technique capable of resolving cortical and trabecular thickness at the distal sites, do not report worsening of cortical structure or trabecular architecture in elderly women with T2D compared to age-matched non-diabetics [8, 9] . However, there is evidence of increased intra-cortical porosity in some diabetic cohorts [8, 10] , especially if the T2D patient had suffered a fracture [11] . Likewise, T2D post-menopausal women with a fracture had thinner cortices at the femoral neck compared to those without fractures [12] . Worsening of bone material properties in diabetes would explain the paradox that aBMD is higher among diabetics compared to non-diabetics, even though diabetes elevates fracture risk [13] .
Unlike material strength (independent of structure) that assesses the ability of a bone to resist permanent deformation, toughness assesses the ability of bone to dissipate energy during failure. For cortical bone, deformation after yielding primarily dictates toughness and primarily depends on the collagen phase. Moreover, there is an association between the age-related decrease in bone toughness or post-yield toughness and the increase in nonenzymatic, glycation-mediated collagen crosslinks (NEGs) [14] . One of these NEGs, pentosidine (PE), is the standard biomarker for advanced glycation end products (AGEs) in bone [15] . Mechanistically, AGE accumulation in the bone matrix is thought to impede collagen fibril deformation, thus reducing energy dissipation and subsequently the fracture resistance of bone [16] . Other major AGE cross-links such as glucosepane are not yet readily measurable in bone [17] . Nonetheless, a diabetic increase in overall bone PE has been directly observed in one study to date involving T2D [18] . In addition to hyperglycemia, oxidative stress enhances non-enzymatic glycation of collagen [19] as the AGE formation often requires an oxidative step. Thus, diabetic bone disease could be more a problem of bone brittleness and less a problem of low bone strength.
The prominent phenotype of most diabetic rat models is structural weakness when compared with age-and gendermatched non-diabetic controls. This has been observed in both cortical and trabecular bone [20, 21] with diabetic rats having lower peak force for both the bending of the femur mid-shaft [21, 22] and the compression of lumbar vertebrae [22, 23] . This difference accompanied lower volumetric BMD for both cortical and trabecular bone [20] [21] [22] . In the Zucker Diabetic Fatty (ZDF) model, the cross-sectional moment of inertia, cortical thickness, and cortical volumetric bone mineral density are all lower in the diabetic than in the non-diabetic rats [21, 22] . However, the differences in bone material properties are not always reproducible and appear to depend on the duration and onset of diabetes [24, 25] .
To advance clinically relevant diagnostic and therapeutic tools, there is a need for pre-clinical models of diabetes in which the fracture resistance of bone decreases with disease progression. Therefore, a thorough assessment of bone changes in rodent models of T2D is required [25] . Including analysis of bones from rats before diabetic onset for the first time, we characterized how the fracture resistance of bone decreases as diabetes progresses in a dietinduced, adult-onset rat model of T2D. In particular, mechanical properties not dependent on aBMD or bone structure were measured in addition to whole-bone strength.
Materials and Methods
Study Design
Twenty-six male CD(SD) rats and 38 male Zucker Diabetic Sprague-Dawley (ZDSD) rats between 6 and 8 weeks of age were purchased from Charles River (Wilmington, MA) and PreClinOmics (Indianapolis, IN), respectively. As one of the parental strains of the ZDSD rat, the CD(SD) rat serves as the non-diabetic control [20, 23, 26, 27] . Under the advisement of PreClinOmics, all rats were switched from standard chow (Purina 5008, LabDiet, St. Louis, MO) to a diet in which 47.7 % kcal came from fat (5SCA, TestDiet, Richmond, IN) ad libitum at 16 weeks of age. Rats were switched back to 5008 after 6-7 weeks. Female ZDSD rats are less resistant to diabetes with one-third to one-half experiencing hyperglycemia at variable ages on a high-fat diet (HFD) such as 5SCA [20] . Non-fasting blood glucose levels were periodically measured using a glucometer (TRUEresult Ò , Nipro Diagnostics, Inc., Fort Lauderdale, FL). Four ZDSD rats died or were killed early because they lost 20 % of their body weight. Two animals were excluded from the study because they either did not develop diabetes or were only hyperglycemic ([250 mg/ dL) for 1 week. As such, bones were harvested from 12 CD(SD) and 14 ZDSD rats at 22 weeks of age and from 14 CD(SD) and 18 ZDSD rats at 29 weeks of age. Fourteen young male CD(SD) and twelve age-matched male ZDSD rats were also purchased and euthanized at 16 weeks without being fed the HFD. None of these rats were hyperglycemic. We used procedures including the method of euthanasia that were approved by the local Institutional Animal Care and Use Committee, which follows the Guide for the Care and Use of Laboratory Animals (8th edition, The National Academies Press, Washington, DC).
Micro-Computed Tomography Analysis (lCT)
Bones were first imaged using a high-resolution lCT scanner (lCT50, Scanco Medical, Brüttisellen, Switzerland) at isotropic voxel sizes of 10 lm (intact long bones and L6 vertebra) and 12 lm (notched femur). The regions of interests (ROIs) were (i) a 4-mm section in the central mid-shaft of an intact femur (right), (ii) a 5-mm section of the distal femur metaphysis (right), (iii) a 4-mm region centered around a micro-notch generated in the posterior side of the contralateral femur (left), (iv) a 1.86-mm section centered at the point of curvature within the radius diaphysis, and (v) the L6 VB (from cranial to caudal end-plates). Using weekly calibration scans of a hydroxyapatite (HA) phantom and a beam hardening correction, linear X-ray attenuation coefficients were converted to volumetric tissue mineral density (TMD).
Post reconstruction, the manufacturer's contouring and evaluation scripts provided standard structural (e.g., Ct.Th, Ct.Ar, I min , C min ), compositional (e.g., Ct.TMD, Tb.TMD), and morphological parameters (e.g., BV/TV, Tb.N, Tb.Th., Conn.D) of bone following published guidelines [28] . As described in our previous study [29] , a global threshold with noise filtering was selected for each region to segment bone from soft tissue and air or pores from bone.
Biomechanical Analysis
Quasi-Static Flexural Tests of Femur and Radius
With the anterior side of the diaphysis facing down, each hydrated bone was monotonically loaded in three-point (3pt) bending at 3.0 mm/min until failure (DynaMight 8841, Instron, Norwood, MA). The span (L) of the lower supports was 14 mm for the radius and between 15 and 17 mm for the femur (span & 5 9 anterior-posterior width). The structure-dependent properties included rigidity (stiffness 9 L 3 /12), peak moment (M p ), and work-tofailure (W f ) adjusting for the span. Then, using the lCTderived structural parameters, we estimated the modulus (rigidity/I min /4), material strength or peak bending stress (M p 9 C min /I min /4), and toughness (3 9 W f /Ct.Ar/L) as previously described for the analysis of force versus displacement data from a flexural test [29, 30] . Post-yield displacement (PY disp ) was measured as displacement between the yield point and the displacement at fracture.
Fracture Toughness Testing of Notched Femur
After generating a micro-notch at the mid-point of the diaphysis on the posterior side [29] , the contralateral femurs were also monotonically loaded to failure in 3pt bending but at 0.06 mm/min and with the posterior side facing down in order to propagate a crack. Using the previously published equations presented in [31] , the fracture toughness was determined as the critical stress intensity (K c ) occurring at the initial micro-notch under the peak force endured by the bone. Cracking toughness (i.e., energy to propagate the crack) was measured by the span-adjusted W f divided by the Ct.Ar.
Compositional Analyses
Raman Spectroscopy (RS) Following our previously described methods for Raman analysis of intact mouse femurs [32, 33] , each rat femur (right) was mounted with the anterior side facing up under a 50X objective (NA = 0.75) of a confocal Raman microscope (InVia, Renishaw, Hoffman Estates, IL) equipped with a 785-nm laser diode source (Innovative Photonic Solutions, Monmouth Junction, NJ). After blotting the wet surface with a Kimwipe, the periosteal surface was brought into focus under the bright field. At 3 sites along the mid-shaft ( Fig. 1 ), spectra were collected with 7 accumulations of 12 s exposures of 35 mW laser power. Following cosmic spike removal and subtraction of background fluorescence [33] , the spectra provided compositional properties as follows: the mineral-to-matrix ratio, type B carbonate substitution, and crystallinity (Fig. 1) . The average of the three sites per bone was used in the statistical analysis.
High-Performance Liquid Chromatography (HPLC)
HPLC analysis was performed on a 4-mm cross-section of the left femur mid-shaft after biomechanical testing. Bone segments were demineralized in 20 % ethylenediaminetetraacetic acid (EDTA) at 4°C. The segments were hydrolyzed in 6 N HCl with 4.5 mM alpha-amino-N-butyric acid (a-ABA) for *20 h. To determine collagen content, 500 lL of ethanol, triethylamine, and water (2:1:2) were first added to *1 mg of each filtered sample as well as to standards consisting of hydroxyproline, proline, and a-ABA. They were subsequently derivatized with ethanol, water, phenylisothiocyanate (PITC), and triethylamine (7:1:1:1) and re-suspended in a diluent buffer of 0.071 % disodium phosphate (Na 2 HPO 4 ) in 5 % acetonitrile [34] . Samples and standards were injected into a column for hydrolysate amino acid analysis (Waters PicoTag Ò , Milford, MA), and the amino acids were eluted using 1.9 % sodium acetate plus 0.05 % acetonitrile and 60 % acetonitrile as the mobile phase (Beckman Coulter System Gold 126, Brea, CA). The chromatogram was generated using a UV detector (Beckman Coulter 168 Detector, Brea, CA). Collagen content was determined from the measurement of hydroxyproline. Since the hydroxyproline was two times higher than the expected value for 8 of the 84 samples, a correction was applied based on the regression between collagen mass and wet mass.
To determine crosslink concentrations, another portion of the hydrolyzed bone sample was re-suspended in 0.25 lg/mL of pyridoxine (PYR) in HPLC-grade water. The samples were mixed (1:1) with dilution buffer, which consisted of 10 % HPLC-grade acetonitrile and 0.5 % heptafluorobutyric (HFBA) as the ion-pairing agent. Samples were injected along with standards consisting of PYR and varying concentrations of pyridinoline (PYD), deoxypyridinoline (DPD), and pentosidine (PE) into a silica-based, reversed-phase C18 column (Waters Spherisorb Ò 5 lm ODS2, Milford, MA). Crosslinks were separated with two mobile phases of 0.22 % HFBA and 100 % acetonitrile at 87/13 (PYD and DPD) and 25/75 (PE), respectively. A programmable fluorescence detector (Waters 2475 Multi k Fluorescence Detector) was used to generate chromatograms. Moles of each crosslink per sample were divided by the corresponding moles of collagen.
Statistical Analysis
All statistical analyses were done using GraphPad Prism (v6.0a, GraphPad Software, Inc., La Jolla, CA). Because the majority of the outcome measures either did not pass the Shapiro-Wilk normality test for at least one experimental group or the variance was significantly different among the six experimental groups (Brown-Forsythe Test), the Kruskal-Wallis test was used to determine whether each property differed among the experimental groups. When group means were not the same, three different multiple pair-wise comparisons were done: (i) 16 weeks versus 22 weeks, 16 weeks versus 29 weeks, and 22 weeks versus 29 weeks within CD(SD), (ii) 16 weeks versus 22 weeks, 16 weeks versus 29 weeks, and 22 weeks versus 29 weeks within ZDSD, and (iii) CD(SD) versus ZDSD within each age group (16, 22, and 29 weeks) . In each of these post hoc tests of three comparisons, the nonparametric Dunn's test provided the adjusted p value for a family-wise significance level of 0.05. Differences in body weight and glucose between the rat strains were determined using Mann-Whitney tests at each time point.
Results
Changes in Weight and in Glucose Levels with the Progression of Diabetes
Other than one ZDSD rat that was diabetic (C250 mg/dL) at baseline, the ZDSD rats became diabetic within 2 weeks of switching from standard chow to the 5SCA HFD (Fig. 2a) . The control CD(SD) rats remained normoglycemic (Fig. 2a) and became obese on the HFD (Fig. 2b) . The ZDSD rats on the HFD actually lost weight as the duration of T2D increased (Fig. 2b) .
Loss of Trabecular Bone with the Progression of Diabetes
In the distal femur metaphysis (DFM) and L6 VB, the trabecular bone volume fraction did not change in CD(SD) rats between 16 and 29 weeks of age, whereas it declined significantly in diabetic ZDSD rats (Table 1) . During the 12-13 weeks of diabetes that the ZDSD rats experienced, the trabeculae became thinner, whereas Tb.Th increased in non-diabetic controls over the same time period, namely in the VB (Table 1) . Also, there were fewer trabeculae at 29 weeks than at 16 weeks for only the ZDSD rats. Differences in connectivity density (Conn.D) between the rat strains were not significant, regardless of age. The tissue mineral density of trabeculae (Tb.TMD) increased with age (DFM and VB) in both diabetic and control rats. However, the rate increase was lower among the ZDSD rats such that Tb.TMD was significantly lower for the diabetic than for the non-diabetic rats at 29 weeks.
Strain-Related Differences in Cortical Structure but Diabetes-Related Differences in Micro-Structure
For both long bones, we found structural differences in the cortex of the mid-shaft between CD(SD) and ZDSD rats that were independent of diabetes. The average moment of Fig. 2 Non-fasting glucose levels over time after switching to a highfat diet (a) and body weight versus age (b). ZDSD rats had significantly higher glucose levels than CD(SD) rats by 17 weeks. CD(SD) rats became obese on the HFD but ZDSD rats began to lose weight. Asterisks indicate significant difference between ZDSD and CD(SD) values Table 1 Selected architectural properties of trabecular bone (mean ± SD) as determined from lCT analysis of the distal femur metaphysis and lumbar vertebra of non-diabetic CD(SD) rats and ZDSD rats at different ages (and duration of hyperglycemia) Property inertia (I min ) of the diaphysis, the periosteal perimeter (Ps.Pm), and the length of the long bones were lower in the ZDSD than in the CD(SD) rats at all age groups ( Table 2) . Regardless of rat strain, I min , cross-sectional area of cortical bone (Ct.Ar), and cortical thickness (Ct.Th) of each mid-shaft were lower at 16 weeks than at 22 and 29 weeks. In effect, T2D did not affect normal age-related increase in the structure of either of the long bones between 16 and 22 weeks. This is also evident in total cross-sectional area (Tt.Ar) and Ps.Pm, which were higher for the older ZDSD rats than for 16-week-old rats (Table 2) . Unlike the structural parameters, there were no strainrelated differences in intra-cortical porosity (Ct.Po) at 16 or 22 weeks of age (Fig. 3) . However, there was a diabetesrelated increase in Ct.Po of the femur mid-shaft such that Ct.Po and pore number were higher in the diabetic rats than in control rats at 29 weeks of age (Fig. 3) .
Similar Age-Related Changes in Biomechanical Properties of Non-diabetic and Diabetic Bone
Given the age-related increase in I min , whole-bone strength and rigidity of both the radius and femur were higher at 29 weeks than at 16 weeks for both strains (Table 2) . Before the change in diet, the radius was stronger for the CD(SD) than for the ZDSD rats, but no strain-related difference in peak moment (M p ) existed for the femur. Post-yield displacement (PY disp ) of the femur did not vary among the groups, while PY disp of the radius decreased with age for both the rats but less for the diabetic ZDSD rats, though not statistically significant.
Diabetes-Related Changes in the Estimated Material Properties
The material strength or peak bending stress of cortical bone significantly increased from 16 to 29 weeks of age in the CD(SD) rats, whereas it did not significantly vary with age in the diabetic ZDSD rats (Fig. 4a) . Interestingly, Ct.TMD, a determinant of material strength, increased with age for both the rat strains (Table 2 ). Compared to 16 weeks, toughness (radius only) was lower at 22 weeks and 29 weeks in the diabetic rats only (Fig. 4b) . Unlike bending strength, there were no differences in toughness between the strains at 16 weeks of age, but toughness (radius only) was significantly lower for the diabetic bone than for the non-diabetic bone at 29 weeks. When a crack was propagated from a notched femur, there was a difference in crack initiation toughness (K c,int ) between the rat strains at 16 weeks before hyperglycemia (Fig. 4c) . Interestingly, K c,int and cracking toughness (Fig. 4d ) did not vary with age for CD(SD) rats but decreased with duration of diabetes in the ZDSD rats such that the higher fracture toughness properties in ZDSD rats at 16 weeks were no longer different between the groups at 29 weeks.
Diabetes-and Age-Related Changes in Bone Composition
With respect to the compositional properties of bone tissue (femur), the mineral-to-matrix ratio (MMR) was higher for the ZDSD rats than for the CD(SD) rats at all age groups for both t 1 PO 4 /Amide I and t 1 PO 4 /Proline, but these strainrelated differences were only significant at 22 and 29 weeks. Fig. 3 lCT analysis of porosity in cortical bone within the femoral mid-shaft of ZDSD and CD(SD) rats. Cortical porosity and pore number were higher for ZDSD than for CD(SD) rats at 29 weeks. c p = 0.0006 for CD(SD) versus ZDSD at 29 weeks Moreover, MMR increased with age, regardless of strain (Table 3) . Interestingly, crystallinity did not vary with age in the non-diabetic rats, but was higher after diabetic onset in the ZDSD rats. Although diabetes was a significant factor explaining the variance in pentosidine when accounting for age and body weight (Supplemental Table 1 ), there were no significant differences in PE between the non-diabetic CD(SD) and diabetic ZDSD rats at each age (Fig. 5) . The mature enzymatic collagen crosslinks (pyridinolines or PYD) increased with age in both the strains.
Discussion
Skeletal fragility is now recognized as a complication associated with T2D [35] , but yet the underlying causes for the increased fracture risk among diabetics are currently not known. The present study supports, in part, the use of the ZDSD rat as a model of diabetic bone disease. Unlike the ZDF rat, ZDSD rats have normal leptin signaling and thus avoid the potential confounding effects of reduced leptin signaling in the hypothalamus on bone [36, 37] . Also, being a diet-induced model of T2D, overt hyperglycemia can be initiated after the animal reaches skeletal maturity within 2 weeks. Most importantly, cortical bone progressively lost toughness (radius) and fracture toughness (femur) with the progression of diabetes. That is, diabetic ZDSD rats experience the hypothesized brittle effect that can also occur with advanced aging and possibly diabetes in humans. They also exhibit diabetes-related increase in cortical porosity, albeit the increase is small at 29 weeks (Fig. 3) . There are however a number of confounding issues with the ZDSD rat as follows: (i) the ZDSD rats can also lose body weight as diabetes
(e) (f) Fig. 4 Selected apparent-level material properties as determined by flexural tests of long bones. With aging, estimated material strength of the radius (a) and femur (b) increased for the CD(SD) rats but did not change for the ZDSD rats. As the duration of T2D increased, toughness decreased for the ZDSD rats (c radius only), but toughness did not vary with age for the non-diabetic rats (c, d).
Resistance to crack initiation (e) and energy to propagate a crack to failure (f) also decreased with increasing duration of diabetes in ZDSD rats. progresses; (ii) there are structural differences in the diaphysis between ZDSD and control before the onset of hyperglycemia; (iii) differences in material strength and fracture toughness between the rat strains exist before but not after diabetic onset; (iv) trabecular bone volume fraction decreases with diabetes duration, which has not yet been observed in humans with T2D; and (v) AGEs in bone are not different from control, though they appear to accumulate with diabetes duration. One potential way to mitigate the weight loss in the ZDSD rat could involve stopping the HFD-used to time the onset of hyperglycemia-after 2 weeks. This assumes that the high fat is driving the overt hyperglycemia and subsequent increase in glycosuria. However, when the ZDSD male rats were solely fed Purina 5008 chow (16.7 % kcal) in a different study, there was a similar weight gain through maturation, as in the present study, peaking around 23 weeks (564.4 ± 8.2 g) and a subsequent significant weight loss over the next 8 weeks [27] . Of note, with Purina 5008 diet, the onset of overt diabetes in ZDSD rats was variable with the majority exceeding 250 mg/dL between 21 and 23 weeks, instead of between 16 and 18 weeks when consuming 5SCA. In another study in which 16-week-old CD(SD) male rats and ZDSD male rats were fed the 5SCA HFD between 16 and 22 weeks, similar to the present study, the ZDSD rats (424 ± 15 g) weighed significantly less than the CD(SD) rats 527 ± 11 g) at 34 weeks [38] . ZDSD rat is obviously not a model of obesityassociated diabetes.
Several previous studies have also documented differences in trabecular architecture and cortical structure between CD(SD) and ZDSD rats. In the first reported study in which male rats were fed Purina 5008 until death (33 weeks), Reinwald et al. [23] found that trabecular bone volume in the L4 VB was less for diabetic ZDSD than for the non-diabetic CD(SD) strain as determined by lCT. Using HR-pQCT to assess the cortical structure of the femur diaphysis, cortical area and cortical thickness were all lower in the ZDSD rats. A conclusion to be drawn from the study is that diabetes worsens cortical bone structure, but strain-related differences in structure, namely moment of inertia, can exist prior to the ZDSD rats developing frank diabetes (Table 2 ). In the present study, BV/TV in the distal femur was not different between the rat strains at 16 weeks but was lower for the ZDSD rats after 12-13 weeks of diabetes (Table 1) . Moreover, in a previous study comparing non-diabetic ZDSD rats to diabetic ZDSD rats (females fed 5SCA between 21 and 33 weeks) [20] , BV/TV in the distal femur was lower for the diabetic rats. To the best of our knowledge, the present study is the first to report that normal age-related changes in the cortical structure of the mid-shaft occurs in diabetic ZDSD male rats, while a diabetes-related loss in trabecular bone Table 3 Selected compositional properties of cortical bone (mean ± SD) as determined from Raman spectroscopy analysis of the femur mid-shaft Property unit 16 weeks of age (baseline data) The mineral-to-matrix ratio (MMR) was determined by two ratios: the prominent phosphate peak normalized to either the Amide I peak or the proline peak (Fig. 1) also occurs. Also, the age-related increases in structure (I min ) and peak moment that occurred in both rat strains (Table 2 ) remained significant when accounting for the contribution of body weight (BW) to bone strength (Supplemental Table 1 ).
Several studies reported variable differences in the material properties between male CD(SD) and male ZDSD rats. In the initial report by Reinwald et al. [23] , there were no significant differences in either peak bending strength or toughness (femur). Subsequently, Gallant et al. [39] reported lower bending strength and lower toughness of cortical bone for ZDSD rats compared to CD(SD) controls. Rats in the latter study were fed a HFD starting at 20 weeks for 12 weeks, suggesting that HFD may exacerbate the effects of diabetes on material properties of bone. However, in the aforementioned female ZDSD study [20] , material properties were not significantly different. Presently, material strength, fracture toughness, and cracking toughness were higher for the ZDSD than for the male CD(SD) rats at 16 weeks, but these material properties did not change or significantly decreased with diabetes duration in the ZDSD rat (Fig. 4) . As a possible explanation for this lack of an age-related increase in material strength, circulating insulin decreases from normal levels with the progression of diabetes in ZDSD rats (Supplemental Fig. 1) . Thus, the progression of diabetes in ZDSD male rats apparently affects the mechanical properties of the bone, in particular toughness and fracture toughness. However, the use of male CD(SD) rats as a control complicates this interpretation of diabetic effects on material properties as differences in the fracture properties and bending strength between the two rat groups are not significant at 29 weeks. Differences in BW between CD(SD) and ZDSD rats do not explain the lack of an agerelated increase in the bending strength in ZDSD rats as body weight was not a significant explanatory variable of this material property (Supplemental Table 1 ). NEG crosslinking in collagen (i.e., AGE accumulation) is thought to decrease the toughness of bone by preventing fibril sliding and energy dissipation of the tissue [19] . Saito et al. [40] analyzed bones using the male WBN/Kob rat model of spontaneous T2D (no diet manipulation) in which male Wistar rats served as non-diabetic controls and reported that PE in the femoral cortex was higher for the T2D animals starting at 12 months (52 weeks). The onset of overt diabetes in this study occurred between 10 and 12 months with body weight significantly decreasing between 12 and 14 months in only WBN/Kob rats. As with this other rat model of T2D, we found that PE in the femoral cortex of the ZDSD rat increased with duration of diabetes, but no significant difference in PE between non-diabetic and diabetic bone. Possibly, to establish a difference in AGEs between non-diabetic and diabetic bone in ZDSD rats requires animals older than 29 weeks, longer duration of diabetes than 12 weeks, and/or non-obese animals as controls.
A previous study in which CD(SD) and ZDSD male rats were fed 5SCA for 2 weeks starting 17 weeks [26] also found higher MMR in the long bones (tibia) of the diabetic than those of the non-diabetic rats. Since we included 16-week-old rats, we were able to observe that diabetes does not impede age-related accumulation of mineral in the matrix. One interpretation of the difference in MMR between non-diabetic and diabetic bone is that diabetes affects the amount of collagen. However, Raman is sensitive to the inherent polarization bias [41] , so what could actually be different between CD(SD) and ZDSD rats is collagen fibril orientation. The discrepancy in the duration-related decrease in bone toughness between the radius and femur is likely due to the limitations inherent in the mechanical testing of rodent long bones. Since machining uniform specimens from the cortex is exceedingly difficult and impractical, material properties like toughness are estimated from flexural tests of the diaphysis. Being more slender, the radius experiences less shear than does the femur and so its toughness is dictated more so by tensile behavior of the tissue. We cannot however rule out the role of anatomical differences in how diabetes affects bone (e.g., differences in load bearing between the radius and femur). Nonetheless, the present study suggests that testing two different bones is useful in identifying how diabetes affects fracture resistance. The study also suggests that non-diabetic ZDSD rats would be a better a control than CD(SD) rats. Since female ZDSD rats are less susceptible to diabetes than male ZDSD rats fed a high-fat diet, they would likely provide approximately equal numbers of non-diabetic and diabetic rats.
The HFD also appears to help time the onset of diabetes (i.e., rats become hyperglycemic at the same age).
As diabetes progressed in the ZDSD rats, there were decreases in toughness and fracture toughness of cortical bone with no change in material strength, whereas bones from non-diabetic rats between 16 and 29 weeks exhibited an increase in material strength of cortical bone but no changes in toughness and fracture toughness. While there are limitations to using the ZDSD rat as a model of diabetic bone disease, this model does implicate tissue-level properties as factors contributing to diabetic bone disease.
